iNCOVACC was developed in partnership with Washington University St. Louis, which had designed and developed the recombinant adenoviral vectored constructs and evaluated them in preclinical studies for efficacy
CHMP recommendation based on safety, tolerability, and immunogenicity data from a Phase 2/3 trial of the Omicron BA.1-adapted bivalent vaccine
India is at the forefront of research in cardiology worldwide but making indigenous products is what we are lacking & it needs to be improved
The Phase IV DREAM-CKD trial will enrol 1004 CKD patients in India, including 502 dialysis dependent, 502 dialysis independent CKD patients with anemia.
This industry-academia collaboration will provide students with an opportunity to participate in research activities with multiple international universities and scientists
It is high time that India assumed a leadership role in healthcare.
The drive also conducted a mega health camp, cancer screening for women and men, ENT screening for children, and blood donation drive
The summit to demonstrate revolutionary techniques and advanced medical procedures for treating CTO
Ascletis is China's first biotech company which has obtained IND approvals of an oral RdRp inhibitor from both China NMPA and the U.S. FDA
This biopharmaceutical facility is one most significant private sector investment ever in the Middletown region
Subscribe To Our Newsletter & Stay Updated
